Author:
Zhao Yanjie,Chen Rong,Zhang Ting,Chen Chaoyue,Muhelisa Muhetaer,Huang Jingting,Xu Yan,Ma Xuelei
Abstract
BackgroundDifferential diagnosis between benign and malignant breast lesions is of crucial importance relating to follow-up treatment. Recent development in texture analysis and machine learning may lead to a new solution to this problem.MethodThis current study enrolled a total number of 265 patients (benign breast lesions:malignant breast lesions = 71:194) diagnosed in our hospital and received magnetic resonance imaging between January 2014 and August 2017. Patients were randomly divided into the training group and validation group (4:1), and two radiologists extracted their texture features from the contrast-enhanced T1-weighted images. We performed five different feature selection methods including Distance correlation, Gradient Boosting Decision Tree (GBDT), least absolute shrinkage and selection operator (LASSO), random forest (RF), eXtreme gradient boosting (Xgboost) and five independent classification models were built based on Linear discriminant analysis (LDA) algorithm.ResultsAll five models showed promising results to discriminate malignant breast lesions from benign breast lesions, and the areas under the curve (AUCs) of receiver operating characteristic (ROC) were all above 0.830 in both training and validation groups. The model with a better discriminating ability was the combination of LDA + gradient boosting decision tree (GBDT). The sensitivity, specificity, AUC, and accuracy in the training group were 0.814, 0.883, 0.922, and 0.868, respectively; LDA + random forest (RF) also suggests promising results with the AUC of 0.906 in the training group.ConclusionThe evidence of this study, while preliminary, suggested that a combination of MRI texture analysis and LDA algorithm could discriminate benign breast lesions from malignant breast lesions. Further multicenter researches in this field would be of great help in the validation of the result.
Reference37 articles.
1. Global Cancer Incidence and Mortality Rates and Trends–an Update;Torre;Cancer Epidemiology Biomarkers Prevention: Publ Am Assoc Cancer Research Cosponsored by Am Soc Prev Oncol,2016
2. Breast Cancer Statistics, 2017, Racial Disparity in Mortality by State;DeSantis;CA: Cancer J Clin,2017
3. Cancer Statistics, 2018;Siegel;CA: Cancer J Clin,2018
4. A Review of Systematic Reviews of the Cost-Effectiveness of Hormone Therapy, Chemotherapy, and Targeted Therapy for Breast Cancer;Diaby;Breast Cancer Res Treat,2015
5. MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer;Orel;Radiology,2001
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献